These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7285475)

  • 21. [Dermis collagens: beyond their structural properties].
    Ruggiero F; Roulet M; Bonod-Bidaud C
    J Soc Biol; 2005; 199(4):301-11. PubMed ID: 16738524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts.
    Byers PH; Holbrook KA; Barsh GS; Smith LT; Bornstein P
    Lab Invest; 1981 Apr; 44(4):336-41. PubMed ID: 6259441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
    Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
    Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collagen disease: a new perspective.
    Mainardi CL; Kang AH
    Am J Med; 1981 Dec; 71(6):913-5. PubMed ID: 7315853
    [No Abstract]   [Full Text] [Related]  

  • 25. Biosynthesis of collagen and its alterations in pathological states.
    Kivirikko KI; Risteli L
    Med Biol; 1976 Jun; 54(3):159-86. PubMed ID: 181643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inherited collagen disorders.
    Sykes B
    Mol Biol Med; 1989 Feb; 6(1):19-26. PubMed ID: 2666815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels.
    Kuivaniemi H; Tromp G; Prockop DJ
    Hum Mutat; 1997; 9(4):300-15. PubMed ID: 9101290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Connective tissue diseases with cutaneous manifestation (author's transl)].
    Lapière CM
    Ann Dermatol Venereol; 1978 Nov; 105(11):905-11. PubMed ID: 754606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular heterogeneity of collagen].
    Slutskiĭ LI; Simkhovich BZ
    Usp Sovrem Biol; 1980; 89(1):58-73. PubMed ID: 6994387
    [No Abstract]   [Full Text] [Related]  

  • 30. Defects in the processing of procollagen to collagen are demonstrable in cultured fibroblasts from patients with the Ehlers-Danlos and osteogenesis imperfecta syndromes.
    Minor RR; Sippola-Thiele M; McKeon J; Berger J; Prockop DJ
    J Biol Chem; 1986 Jul; 261(21):10006-14. PubMed ID: 3733683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
    Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
    Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defects in the biochemistry of collagen in diseases of connective tissue.
    Uitto J; Lichtenstein JR
    J Invest Dermatol; 1976 Feb; 66(02):59-79. PubMed ID: 1448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modifications in the organization and expression of collagen genes associated with skeletal disorders.
    Lee B; D'Alessio M; Ramirez F
    Crit Rev Eukaryot Gene Expr; 1991; 1(3):173-87. PubMed ID: 1802109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type IIA procollagen in development of the human intervertebral disc: regulated expression of the NH(2)-propeptide by enzymic processing reveals a unique developmental pathway.
    Zhu Y; McAlinden A; Sandell LJ
    Dev Dyn; 2001 Apr; 220(4):350-62. PubMed ID: 11307168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biosynthesis of collagen and its disorders (second of two parts).
    Prockop DJ; Kivirikko KI; Tuderman L; Guzman NA
    N Engl J Med; 1979 Jul; 301(2):77-85. PubMed ID: 36559
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vascular Ehlers-Danlos syndromes--biochemical and molecular-genetic investigations].
    Lund AM
    Ugeskr Laeger; 2006 Feb; 168(9):915-20. PubMed ID: 16513057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta.
    Tenni R; Valli M; Rossi A; Cetta G
    Am J Med Genet; 1993 Jan; 45(2):252-6. PubMed ID: 8456811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Osteogenesis imperfecta. Up-to-date review (author's transl)].
    Collado F; García J; Garcia R; Rodríguez JI
    An Esp Pediatr; 1982 Mar; 16(3):229-37. PubMed ID: 6125119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface located procollagen N-propeptides on dermatosparactic collagen fibrils are not cleaved by procollagen N-proteinase and do not inhibit binding of decorin to the fibril surface.
    Watson RB; Holmes DF; Graham HK; Nusgens BV; Kadler KE
    J Mol Biol; 1998 Apr; 278(1):195-204. PubMed ID: 9571043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant splicing of the type III procollagen mRNA leads to intracellular degradation of the protein in a patient with Ehlers-Danlos type IV.
    Thakker-Varia S; Anderson DW; Kuivaniemi H; Tromp G; Shin HG; van der Rest M; Glorieux FH; Ala-Kokko L; Stolle CA
    Hum Mutat; 1995; 6(2):116-25. PubMed ID: 7581395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.